FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification Important Update on FDA Changes Concerning Peptides FDA Tracker for Cell and Gene Therapies in 2026 Alliance for Regenerative Medicine posted on the topic LinkedIn FDA Peptide Update: Category 2 Removals Explained